Vida Ventures Advisors, LLC
- SEC CIK
- 0001831423
- Latest filing
- Nov 3, 2025
Holdings in Q1 2024
Holdings as of Mar 31, 2024, filed Apr 12, 2024. Long positions only; changes compare share counts with Q4 2023.
- Positions
- 5
- −2 vs. Q4 2023
- Portfolio value
- $180.0M
- +$96.0M (+114.3%) vs. Q4 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| KYTXKyverna Therapeutics, Inc. | COM | 4,523,924 | $112.4M | 62.4% | +4,523,924 | New | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 3,931,818 | $44.4M | 24.7% | 00.0% | Unchanged | History |
| DYNDyne Therapeutics, Inc. | COM | 407,499 | $11.6M | 6.4% | −1,667,288−80.4% | Reduced | History |
| ALLOAllogene Therapeutics, Inc. | COM | 1,798,163 | $8.04M | 4.5% | 00.0% | Unchanged | History |
| KRONKronos Bio, Inc. | COM | 2,765,314 | $3.59M | 2.0% | 00.0% | Unchanged | History |
Sold out since Q4 2023 (3)
Positions held at the end of Q4 2023 that are gone from this filing.